Delayed Myocardial Enhancement in Pediatric Hypertrophic Cardiomyopathy: Correlation with LV Function, Echocardiography, and Demographic Parameters.

about

Delayed Myocardial Enhancement in Pediatric Hypertrophic Cardiomyopathy: Correlation with LV Function, Echocardiography, and Demographic Parameters.

Item

http://www.wikidata.org/entity/Q38841287

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Delayed Myocardial Enhancement ...... y, and Demographic Parameters.

@en

type

Item

label

Delayed Myocardial Enhancement ...... y, and Demographic Parameters.

@en

prefLabel

Delayed Myocardial Enhancement ...... y, and Demographic Parameters.

@en

P1476

Delayed Myocardial Enhancement ...... y, and Demographic Parameters.

@en

P2093

Ahmed Kharabish

http://www.w3.org/2001/XMLSchema#string

Mervat Shafik

http://www.w3.org/2001/XMLSchema#string

Noha Hossam Behairy

http://www.w3.org/2001/XMLSchema#string

Reem Esmail

http://www.w3.org/2001/XMLSchema#string

Sonia El Saiedi

http://www.w3.org/2001/XMLSchema#string

Wesam El Mozy

http://www.w3.org/2001/XMLSchema#string

Zeinab Salah Seliem

http://www.w3.org/2001/XMLSchema#string

P2860

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.

The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance.

Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.

MRI of hypertrophic cardiomyopathy: part 2, Differential diagnosis, risk stratification, and posttreatment MRI appearances.

Detection of myocardial disorders by magnetic resonance spectroscopy.

Prediction of ventricular arrhythmias using cardiovascular magnetic resonance.

Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.

The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.

Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy.

P2888

s00246-017-1612-y

P304

1024-1031

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00246-017-1612-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084744124

http://www.w3.org/2001/XMLSchema#string

P698

28401251

http://www.w3.org/2001/XMLSchema#string

P921

echocardiography

demographics